• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国住院房颤患者的中风及其他心血管并发症负担

Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.

作者信息

Cotté Francois-Emery, Chaize Gwendoline, Gaudin Anne-Françoise, Samson Adeline, Vainchtock Alexandre, Fauchier Laurent

机构信息

Bristol-Myers Squibb, Health Economics & Outcomes Research, Rueil-Malmaison, France

HEVA, Lyon, France.

出版信息

Europace. 2016 Apr;18(4):501-7. doi: 10.1093/europace/euv248. Epub 2015 Dec 30.

DOI:10.1093/europace/euv248
PMID:26718532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4865060/
Abstract

AIMS

Atrial fibrillation (AF) is associated with numerous cardiovascular complications. We sought to estimate the annual burden of cardiovascular complications in AF patients in French hospitals.

METHODS AND RESULTS

All AF patients hospitalized in France in 2012 were identified from the national public/private hospital database. Comorbid conditions and medical histories were documented using medical records dating back 5 years. Reasons for hospitalization, type of admission (emergency or otherwise), length of stay, rehabilitation transfers, and death at discharge were identified and costs of acute and rehabilitation care determined (2012 Euros). In total, 533 044 AF patients (mean age ± SD 78.0 ± 11.4 years, 47.1% women) were hospitalized in 2012 for any reason. Hospitalizations were cardiovascular-related in 267 681 patients [22.5% cardiac dysrhythmia, 18.3% heart failure, 7.1% vascular/ischaemic diseases, 6.9% stroke/transient ischaemic attack (TIA)/systemic embolism (SE), and 1.3% haemorrhages]. Patients with stroke/TIA/SE had higher rates of emergency admission (68.1%), transfer to rehabilitation unit (28.1%), and death at discharge (13.7%) than those with other cardiovascular complications, with the exception of haemorrhages, where emergency admission rates were similar. They also had longer mean lengths of stay (12.6 ± 13.2 days for acute care and 46.8 ± 42.5 days for rehabilitation). The annual total cost (acute care and rehabilitation) for all hospitalized cardiovascular events was €1.94 billion, of which heart failure represented €805 million, vascular/ischaemic diseases €386 million, stroke €362 million, cardiac dysrhythmia €341 million, and haemorrhage €48 million.

CONCLUSION

Half a million patients with AF were hospitalized in France in 2012. Cardiovascular-related hospitalizations involved half of these admissions, for a global burden of almost €2 billion, equivalent to 2.6% of total expenditure in French hospitals. Among these hospitalizations stroke/TIA/SE represented costly, but potentially preventable, complications.

摘要

目的

心房颤动(AF)与众多心血管并发症相关。我们试图估算法国医院中AF患者心血管并发症的年度负担。

方法与结果

从国家公立/私立医院数据库中识别出2012年在法国住院的所有AF患者。使用可追溯5年的病历记录并存疾病和病史。确定住院原因、入院类型(急诊或其他)、住院时间、康复转诊情况以及出院时的死亡情况,并确定急性和康复治疗费用(2012年欧元)。2012年,共有533044例AF患者(平均年龄±标准差78.0±11.4岁,47.1%为女性)因任何原因住院。267681例患者的住院与心血管相关[22.5%为心律失常,18.3%为心力衰竭,7.1%为血管/缺血性疾病,6.9%为中风/短暂性脑缺血发作(TIA)/系统性栓塞(SE),1.3%为出血]。与其他心血管并发症患者相比,中风/TIA/SE患者的急诊入院率(68.1%)、转至康复病房的比例(28.1%)和出院时的死亡率(13.7%)更高,但出血患者除外,其急诊入院率相似。他们的平均住院时间也更长(急性治疗为12.6±13.2天,康复治疗为46.8±42.5天)。所有住院心血管事件的年度总费用(急性治疗和康复)为19.4亿欧元,其中心力衰竭为8.05亿欧元,血管/缺血性疾病为3.86亿欧元,中风为3.62亿欧元,心律失常为3.41亿欧元,出血为4800万欧元。

结论

2012年法国有50万AF患者住院。与心血管相关的住院病例占这些入院病例的一半,总负担近20亿欧元,相当于法国医院总支出的2.6%。在这些住院病例中,中风/TIA/SE是代价高昂但可能可预防的并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9c/4865060/9ffce507271a/euv24803.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9c/4865060/6ac626461033/euv24801.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9c/4865060/2c04aee5be2e/euv24802.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9c/4865060/9ffce507271a/euv24803.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9c/4865060/6ac626461033/euv24801.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9c/4865060/2c04aee5be2e/euv24802.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9c/4865060/9ffce507271a/euv24803.jpg

相似文献

1
Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.法国住院房颤患者的中风及其他心血管并发症负担
Europace. 2016 Apr;18(4):501-7. doi: 10.1093/europace/euv248. Epub 2015 Dec 30.
2
Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.在法国,被诊断为心房颤动的患者中风和出血的发生率和成本。
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):e73-83. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.022. Epub 2013 Oct 8.
3
1.4 times increase in atrial fibrillation-related ischemic stroke and TIA over 12years in a stroke center.在一家卒中中心,12年间房颤相关缺血性卒中和短暂性脑缺血发作增加了1.4倍。
J Neurol Sci. 2017 Aug 15;379:1-6. doi: 10.1016/j.jns.2017.05.022. Epub 2017 May 11.
4
First hospitalization for transient ischemic attack in France: Characteristics, treatments and 3-year outcomes.法国短暂性脑缺血发作首次住院治疗:特征、治疗方法及3年预后
Rev Neurol (Paris). 2016 Feb;172(2):152-9. doi: 10.1016/j.neurol.2015.06.008. Epub 2015 Aug 28.
5
Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.回顾性研究慢性非瓣膜性心房颤动及首次短暂性脑缺血发作、卒中和主要出血相关的总医疗费用。
Curr Med Res Opin. 2009 Dec;25(12):2853-64. doi: 10.1185/03007990903196422.
6
Impact of atrial fibrillation on stroke-related healthcare costs.房颤对卒中相关医疗费用的影响。
J Am Heart Assoc. 2013 Nov 25;2(6):e000479. doi: 10.1161/JAHA.113.000479.
7
Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.伴有附加风险因素的心房颤动/心房扑动患者给美国医疗支付者带来的增量成本负担。
Adv Ther. 2011 Oct;28(10):907-26. doi: 10.1007/s12325-011-0065-6. Epub 2011 Sep 30.
8
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE).需要紧急医疗护理的心房颤动。各收治科室的处理方法及结果。来自意大利心房颤动/扑动注册研究(FIRE)的数据。
Ital Heart J. 2004 Mar;5(3):205-13.
9
Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.在美国,类似于 ATHENA 研究的心房颤动/心房扑动患者的心血管住院费用负担和死亡率。
Clin Cardiol. 2010 May;33(5):270-9. doi: 10.1002/clc.20759.
10
[Acute and post-acute hospitalizations for stroke in France: recent improvements (2007-2009)].[法国中风的急性和急性后期住院治疗:近期改善情况(2007 - 2009年)]
Presse Med. 2012 May;41(5):491-503. doi: 10.1016/j.lpm.2012.01.032. Epub 2012 Mar 6.

引用本文的文献

1
Atrial fibrillation in the Americas.美洲地区的心房颤动。
Lancet Reg Health Am. 2025 May 6;47:101110. doi: 10.1016/j.lana.2025.101110. eCollection 2025 Jul.
2
Comprehensive analysis of lactylation-related gene and immune microenvironment in atrial fibrillation.心房颤动中乳酸化相关基因与免疫微环境的综合分析
Front Cardiovasc Med. 2025 Apr 22;12:1567310. doi: 10.3389/fcvm.2025.1567310. eCollection 2025.
3
Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation.

本文引用的文献

1
Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countries.四个欧洲国家心房颤动患者的维生素K拮抗剂治疗及治疗范围内的时间
Clin Ther. 2014 Sep 1;36(9):1160-8. doi: 10.1016/j.clinthera.2014.07.016. Epub 2014 Aug 21.
2
Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases.与抗凝剂相关的住院情况:通过医院数据库识别出的严重不良反应。
Pharmacoepidemiol Drug Saf. 2015 Feb;24(2):144-51. doi: 10.1002/pds.3688. Epub 2014 Jul 31.
3
Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
在艾因托芬之后100年的电生理学进展:房颤节律控制中的转化与计算创新
Europace. 2024 Dec 26;27(1). doi: 10.1093/europace/euae304.
4
Cost-effectiveness of left atrial appendage occlusion during cardiac surgery in France: An economic evaluation based on the LAAOS III study.法国心脏手术中左心耳封堵术的成本效益:基于 LAAOS III 研究的经济学评价。
PLoS One. 2024 May 9;19(5):e0302517. doi: 10.1371/journal.pone.0302517. eCollection 2024.
5
Identification of Plasmatic MicroRNA-206 as New Predictor of Early Recurrence of Atrial Fibrillation After Catheter Ablation Using Next-generation Sequencing.使用下一代测序技术鉴定血浆微小RNA-206作为导管消融术后心房颤动早期复发的新预测指标
Mol Diagn Ther. 2024 May;28(3):301-310. doi: 10.1007/s40291-024-00698-x. Epub 2024 Mar 8.
6
The Association between Diagnosis-to-Ablation Time and the Recurrence of Atrial Fibrillation: A Retrospective Cohort Study.诊断至消融时间与心房颤动复发之间的关联:一项回顾性队列研究
Diseases. 2024 Feb 9;12(2):38. doi: 10.3390/diseases12020038.
7
Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls.使用前瞻性队列研究和基于人群的对照来估计心房颤动的成本影响。
BMJ Open. 2023 Sep 14;13(9):e072080. doi: 10.1136/bmjopen-2023-072080.
8
The costs associated with stroke care continuum: a systematic review.与卒中护理连续体相关的成本:一项系统综述。
Health Econ Rev. 2023 May 17;13(1):32. doi: 10.1186/s13561-023-00439-6.
9
Early Diagnosis of Atrial Fibrillation and Stroke Incidence in Primary Care: Translating Measurements into Actions-A Retrospective Cohort Study.基层医疗中房颤的早期诊断与卒中发生率:将测量转化为行动——一项回顾性队列研究
Biomedicines. 2023 Apr 7;11(4):1116. doi: 10.3390/biomedicines11041116.
10
Signal Quality Analysis for Long-Term ECG Monitoring Using a Health Patch in Cardiac Patients.使用心脏健康贴片对心脏病人进行长期心电图监测的信号质量分析。
Sensors (Basel). 2023 Feb 14;23(4):2130. doi: 10.3390/s23042130.
达比加群酯与维生素K拮抗剂预防心房颤动患者卒中的成本效益分析:法国医保支付方视角
Arch Cardiovasc Dis. 2014 Jun-Jul;107(6-7):381-90. doi: 10.1016/j.acvd.2014.04.009. Epub 2014 Jun 24.
4
Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.法国心房颤动患者的卒中预防:新型口服抗凝剂(阿哌沙班、达比加群和利伐沙班)、华法林和阿司匹林的成本效果比较。
J Med Econ. 2014 Aug;17(8):587-98. doi: 10.3111/13696998.2014.923891. Epub 2014 May 29.
5
Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database.法国初级保健中房颤患者卒中预防的性别差异。AFIGP(全科医疗中的房颤)数据库的结果。
Clin Res Cardiol. 2014 Nov;103(11):887-93. doi: 10.1007/s00392-014-0726-y. Epub 2014 May 15.
6
Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.老年人房颤的临床病程:心血管事件对中风以外的重要性。
Eur Heart J. 2014 Jan;35(4):250-6. doi: 10.1093/eurheartj/eht483. Epub 2013 Nov 25.
7
Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?住院时间:在非瓣膜性心房颤动患者中,与华法林相比,利伐沙班是否与更短的住院时间相关?
Curr Med Res Opin. 2014 Apr;30(4):645-53. doi: 10.1185/03007995.2013.867843. Epub 2013 Dec 5.
8
Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.在法国,被诊断为心房颤动的患者中风和出血的发生率和成本。
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):e73-83. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.022. Epub 2013 Oct 8.
9
Effect of rehabilitation setting on dependence following stroke: an analysis of the French inpatient database.康复环境对脑卒中后依赖的影响:对法国住院患者数据库的分析。
Neurorehabil Neural Repair. 2014 Jan;28(1):36-44. doi: 10.1177/1545968313497828. Epub 2013 Jul 29.
10
Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients.房颤的发病率和患病率:基于 830 万患者的分析。
Europace. 2013 Apr;15(4):486-93. doi: 10.1093/europace/eus333. Epub 2012 Dec 6.